| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Revenue | $26.9B | $28.6B | $32.0B | $38.2B |
| Cost of Revenue | — | — | $25.8B | $30.7B |
| Gross Profit | — | — | — | — |
| R&D Expense | — | — | — | — |
| SG&A Expense | $0.5B | $0.4B | $0.5B | $0.4B |
| Operating Income | $0.9B | $0.3B | $2.2B | $4.1B |
| Net Income | $0.6B | $0.2B | $1.6B | $2.9B |
| EPS (Basic) | $3.08 | $0.91 | $8.29 | $14.28 |
| EPS (Diluted) | $3.08 | $0.91 | $8.29 | $14.28 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Total Assets | $16.5B | $16.6B | $17.7B | $18.1B |
| Current Assets | $4.8B | $5.0B | $6.1B | $6.7B |
| Cash & Equivalents | $1.0B | $0.8B | $1.4B | $1.7B |
| Total Liabilities | $7.3B | $7.3B | — | — |
| Current Liabilities | $2.5B | $3.0B | $2.8B | $3.2B |
| Stockholders' Equity | $9.2B | $9.3B | $10.2B | $9.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Operating Cash Flow | $1.3B | $1.1B | $2.3B | $3.8B |
| Investing Cash Flow | $-0.5B | $-0.5B | $-0.4B | $-0.8B |
| Capital Expenditures | $0.4B | $0.5B | $0.4B | $0.5B |
| Financing Cash Flow | $-0.6B | $-1.2B | $-2.2B | $-1.6B |